BridgeMD
Tests treatment safety and results for Skin Aging
Official title Effectiveness and Safety of Cellbooster Shape in Healthy Subjects
ClinicalTrials.gov ID: NCT07636512
What this study is testing
- What it's testing
- SUISSELLE has developed a CE marketed (2021) HA-based superficial epidermis/dermis injection filler and skinbooster product, Cellbooster® Shape (CBS). CBS is produced using patented CHAC Technology.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 and older. Healthy volunteers may be eligible.
You may be able to join if
- Healthy subject.
- Sex: male and female.
- Phototype II to IV.
- Age: from 35 years old.
- Subject with light to moderate signs of cutaneous ageing of the face.
You likely can't join if
- In terms of population
- Pregnant or nursing woman or planning a pregnancy during the study.
- Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
- Subject in a social or sanitary establishment.
- Subject participating to another research on human beings or being in an exclusion period for a previous study.
- Subject having received a total of 6.000 euros as compensation for their participation in research involving human beings in the last 12 months...
See the full eligibility criteria
- Healthy subject.
- Sex: male and female.
- Phototype II to IV.
- Age: from 35 years old.
- Subject with light to moderate signs of cutaneous ageing of the face.
- Subject with a skin hydration rate on cheekbones \< 60 UA, measured with Corneometer®.
- Subject with light to moderate localized submental (double chin) and/or malar puffiness (at least 35 in each indication).
- Subject looking for an anti-age improvement using an aesthetic procedure.
- Subject willing to abstain from other facial aesthetic procedure in the full face through the entire study duration.
- Subject having given their free, express, and informed consent.
- Subject psychologically able to understand the information related to the study, and to give their written informed consent.
- Subject registered to a social security scheme.
- Female of childbearing potential must use a medically accepted contraceptive method since at least 12 weeks before the beginning of the study and throughout the study.
- Female people of childbearing potential must have a negative pregnancy test at the inclusion.
- In terms of population
- Pregnant or nursing woman or planning a pregnancy during the study.
- Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
- Subject in a social or sanitary establishment.
- Subject participating to another research on human beings or being in an exclusion period for a previous study.
- Subject having received a total of 6.000 euros as compensation for their participation in research involving human beings in the last 12 months, including their participation in the present study.
- Intensive exposure to sunlight or UV-rays within the previous month and/or planning to do so during the study. In terms of associated pathology 17. Subject with ongoing uncontrolled depression and/or recently recovered...
- anti-inflammatory medication during the previous 2 weeks and during the study.
- anti-histaminics during the previous 7 days.
- immunosuppressors and/or corticoids during the 4 previous weeks and during the study
- retinoids during the 6 previous months and during the study
The study team makes the final eligibility decision.
Where it's taking place
- Villeurbanne, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Villeurbanne, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.